The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Intercept Pharmaceuticals, Inc(NASDAQ:ICPT) 
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for t...
Website: http://www.interceptpharma.com
Founded: 2002
IPO Price: $15 (Oct 11, 2012)
Full Time Employees: 583
CEO: Jerry Durso
Sector: Healthcare
Industry: Biotechnology
Intercept Pharmaceuticals Days Payable Outstanding ttm (DPO)
Intercept Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Intercept Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Intercept Pharmaceuticals Op Cashflow Per Share ttm
Intercept Pharmaceuticals Free Cashflow Per Share ttm
Intercept Pharmaceuticals Cash Per Share ttm
Intercept Pharmaceuticals P/S ratio ttm
Intercept Pharmaceuticals (GAAP) P/E ratio ttm
Intercept Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.